Suchergebnisse - "Mussini, C"

PubPharm (52)

1

Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Chammartin, F. | Mocroft, A. | Egle, A. | +122

2

Long-term outcome of dolutegravir-containing regimens according to sex : data from the ICONA study

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von D'arminio Monforte, A. | Tavelli, A. | Sala, M. | +110

CommentIn: J Antimicrob Chemother. 2023 May 23;:. - PMID 37220765

3

Analysing the efficacy and tolerability of dolutegravir plus either rilpivirine or lamivudine in a multicentre cohort of virologically suppressed PLWHIV

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Ciccullo, A. | Baldin, G. | Borghi, V. | +11

4

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

enthalten in: HIV medicine | 2022

von Byonanebye, D. | Polizzotto, M. | Neesgaard, B. | +90

5

Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency Virus

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2021

von Greenberg, L. | Ryom, L. | Neesgaard, B. | +140

6

Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort

enthalten in: HIV medicine | 2020

von Taramasso, L. | Fabbiani, M. | Nozza, S. | +31

7

HIV MDR is still a relevant issue despite its dramatic drop over the years

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Armenia, D. | Di Carlo, D. | Flandre, P. | +25

8

Virological response and retention in care according to time of starting ART in Italy : data from the Icona Foundation Study cohort

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von d'Arminio Monforte, A. | Tavelli, A. | Cozzi-Lepri, A. | +110

9

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

enthalten in: AIDS research and human retroviruses | 2020

von Lathouwers, E. | Wong, E. | Brown, K. | +108

10

Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Taramasso, L. | Lorenzini, P. | Di Biagio, A. | +110

1
2
3
4
5
6
Nächster »
[6]